Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 2 (4) , 453-457
- https://doi.org/10.1016/s1367-5931(98)80120-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Potent α4β1 Peptide Antagonists as Potential Anti-Inflammatory AgentsJournal of Medicinal Chemistry, 1997
- The pathophysiologic role of alpha 4 integrins in vivo.Journal of Clinical Investigation, 1994
- Novel ψ‐S‐CH2 peptide‐bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu‐Asp‐Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectinInternational Journal of Peptide and Protein Research, 1994
- Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.Journal of Clinical Investigation, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.Journal of Clinical Investigation, 1993
- Monoclonal antibodies to the integrin α−4 subunit inhibit the murine contact hypersensitivity responseEuropean Journal of Immunology, 1993
- Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin.The Journal of cell biology, 1992
- Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules.The Journal of Experimental Medicine, 1991
- Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.The Journal of cell biology, 1989